| Title |
Principal long-term adverse effects of imatinib in patients with chronic myeloid leukemia in chronic phase
|
|---|---|
| Published in |
Biologics: Targets & Therapy, December 2010
|
| DOI | 10.2147/btt.s5775 |
| Pubmed ID | |
| Authors |
Tariq I Mughal, Andrew Schrieber |
X Demographics
The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 1 | 100% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 1 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 149 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Indonesia | 1 | <1% |
| Japan | 1 | <1% |
| United States | 1 | <1% |
| Czechia | 1 | <1% |
| Unknown | 145 | 97% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Bachelor | 35 | 23% |
| Student > Master | 19 | 13% |
| Student > Ph. D. Student | 12 | 8% |
| Student > Doctoral Student | 12 | 8% |
| Researcher | 11 | 7% |
| Other | 23 | 15% |
| Unknown | 37 | 25% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 30 | 20% |
| Biochemistry, Genetics and Molecular Biology | 29 | 19% |
| Pharmacology, Toxicology and Pharmaceutical Science | 14 | 9% |
| Agricultural and Biological Sciences | 11 | 7% |
| Chemistry | 7 | 5% |
| Other | 15 | 10% |
| Unknown | 43 | 29% |
Attention Score in Context
This research output has an Altmetric Attention Score of 7. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 30 March 2021.
All research outputs
#5,339,368
of 25,374,917 outputs
Outputs from Biologics: Targets & Therapy
#72
of 284 outputs
Outputs of similar age
#33,121
of 190,767 outputs
Outputs of similar age from Biologics: Targets & Therapy
#2
of 5 outputs
Altmetric has tracked 25,374,917 research outputs across all sources so far. Compared to these this one has done well and is in the 78th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 284 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 6.2. This one has gotten more attention than average, scoring higher than 74% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 190,767 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 82% of its contemporaries.
We're also able to compare this research output to 5 others from the same source and published within six weeks on either side of this one. This one has scored higher than 3 of them.